Navigation Links
Intarcia Therapeutics Appoints Gino Santini To Its Board Of Directors
Date:7/26/2013

nded periods of time.

Data from Intarcia's ITCA 650 Phase 2 program have demonstrated significant and sustained reductions in HbA1c and body weight over 48 weeks of treatment with a marked reduction in the GI adverse events typically associated with the self-injection products in this class. ITCA 650 is an investigational new therapy and is not currently approved by any regulatory authority. Exenatide, the active agent in ITCA 650, is a glucagon-like peptide-1 (GLP-1) receptor agonist currently marketed globally as twice-daily and once-weekly self-injection therapies for type 2 diabetes. Upon approval, ITCA 650 would represent the first injection-free GLP-1 therapy that can deliver a full year of treatment from a single minipump placement. Intarcia's robust intellectual property portfolio protects ITCA 650 through 2031.

About Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. is a biopharmaceutical company developing therapies to enhance treatment outcomes by optimizing and improving the efficacy, continuous administration and tolerability of drug therapies. In addition, delivering medicines just once or twice yearly virtually ensures patient adherence and compliance, which is very poor in most chronic diseases. Intarcia's drug development expertise and competitive edge are demonstrated by its abilities to stabilize proteins and peptides at above-body temperature and to deliver them in a constant and consistent manner via Intarcia's proprietary technology platform. Intarcia is pursuing a Phase 3-stage development program for type 2 diabetes and has additional programs ongoing for weight regulation to control obesity. For more information on the Company, please visit www.intarcia.com.

Intarcia and its logo are registered trademarks of Intarcia Therapeutics, Inc.


'/>"/>
SOURCE Intarcia Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intarcia Appoints Owen Hughes Chief Business Officer and Head of Corporate Development
2. Intarcia Enrolls First Patients in "FREEDOM" Global Phase 3 Program for ITCA 650 in Type 2 Diabetes
3. Intarcia Supports American Diabetes Association Call For Independent Review Of Incretin-Based Therapies
4. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
5. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
6. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
7. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
8. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
9. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
10. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
11. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014  Researchers from the North American ... elevates calcium levels too high, 1 putting ... problems. Women close to menopause are commonly ... to prevent diseases such as osteoporosis, to which they ... women determine how much calcium they typically get through ...
(Date:7/23/2014)... 23, 2014  The management team at Columbia ... hold a conference call on July 31, 2014, ... ended June 30, 2014.  The call details are ... 8:30 am EDTDial-in numbers: , Toll free: (877) ... (live & archive): , www.columbialabs.com , under ...
(Date:7/23/2014)... , July 23, 2014  Cardica, Inc. (Nasdaq: ... for its fiscal fourth quarter and year ended June 30, ... Cardica,s management will host a conference call at 4:30 p.m. ... update on the company,s business. Conference Call Details ... at 4:30 p.m. Eastern Time via phone, please dial 866-953-6859 ...
Breaking Medicine Technology:Women Taking Too Much Calcium Create Health Risk 2Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results on Thursday, August 7, 2014 2
(Date:7/23/2014)... 2014 Splashtop , a ... that it has joined the RSA Ready Technology ... Enterprise and RSA SecurID® multi-factor authentication solution from ... , Splashtop also announced that leading Japanese ... Splashtop Enterprise, the industry‚Äôs only on-premise remote access ...
(Date:7/23/2014)... July 23, 2014 The Circuelle ... leading academic institutions uncovering the importance of breast ... the need for breast self-exams is contradictory and ... proof today for keeping this healthy ritual. , ... about the significance of breast self-exams and becoming ...
(Date:7/23/2014)... July 22, 2014 (HealthDay News) -- Blood donations to ... agency says an "emergency situation" could arise within weeks. ... 8 percent over the last 11 weeks, resulting in ... in a statement released Tuesday. "The number of donors ... be blamed, in part, on the calendar: This year, ...
(Date:7/23/2014)... July 23, 2014 Follow ... biodegradable substances exclusively developed and manufactured for use ... diseased body tissues. These materials are biosafe with ... host. Global market for biocompatible materials is expected ... as technological advancements and growing base of aging ...
(Date:7/23/2014)... Rock, AR (PRWEB) July 23, 2014 The ... registration for the 2014 Day on the Hill, a one-day ... the goal of bringing awareness to Congress on the importance ... event will take place on September 10, 2014, at the ... CMSA Day on the Hill provides participants with the opportunity ...
Breaking Medicine News(10 mins):Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 2Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 3Health News:Historical and Current Research Points to Importance of Breast Self-Exams 2Health News:American Red Cross Issues Urgent Call for Blood Donations 2Health News:Surge in R&D Investments to Drive the Global Biocompatible Materials Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Surge in R&D Investments to Drive the Global Biocompatible Materials Market, According to New Report by Global Industry Analysts, Inc. 3Health News:CMSA Launches Registration for the 2014 Day on the Hill 2
... ... Help Safeguard Those with Cognitive,Disorders such as Alzheimer,s and Autism , , ... Austin, Texas (PRWEB) January 27, ... tracking solutions, today announced the launch of a tracking solution which answers a critical ...
... , , More ... of The Blues(R) nationwide initiative to improve healthcare quality and ... The Blue Cross and Blue Shield Association (BCBSA) today announced ... Blue Distinction Centers for Spine Surgery(SM) and Blue Distinction Centers ...
... BOSTON (January 27, 2010) Researchers at Tufts University School ... at Tufts have developed a new tool for gene therapy ... compared to other carriers and DNA alone, according to a ... of Gene Medicine . The tool, a peptide called PEG-POD, ...
... , ... driving design with numerical optimization, or just exploring data; accurate and efficient access to data ... ... open source platforms and develops advanced research solutions to overcome the challenges of our time, ...
... N.J. , Jan. 27 ... Jersey State Department of Children and Families domestic violence lead designated ... Graf, Jr. , former CEO of United Way of Somerset ... the Hillsborough, New Jersey -based non-profit  501(c)(3) agency. The Bedminster ...
... ... point that is difficult to ignore in New York, medical malpractice attorneys say. , ... New York, NY (PRWEB) January 27, ... medical care at or above the accepted standards of practice in the medical community. Unfortunately, ...
Cached Medicine News:Health News:FreightWatch Security Net Launches Solution for Tracking and Rescuing Persons at Risk of Wandering 2Health News:FreightWatch Security Net Launches Solution for Tracking and Rescuing Persons at Risk of Wandering 3Health News:FreightWatch Security Net Launches Solution for Tracking and Rescuing Persons at Risk of Wandering 4Health News:Blue Cross and Blue Shield Association Expands Blue Distinction(R) Designation to Include Spine Surgery, Knee and Hip Replacement 2Health News:Blue Cross and Blue Shield Association Expands Blue Distinction(R) Designation to Include Spine Surgery, Knee and Hip Replacement 3Health News:Blue Cross and Blue Shield Association Expands Blue Distinction(R) Designation to Include Spine Surgery, Knee and Hip Replacement 4Health News:Blue Cross and Blue Shield Association Expands Blue Distinction(R) Designation to Include Spine Surgery, Knee and Hip Replacement 5Health News:Researchers develop new tool for gene delivery 2Health News:Open Source Company Kitware Announces New Availability to its MIDAS Server to Further Research Collaboration and Open Science 2Health News:Open Source Company Kitware Announces New Availability to its MIDAS Server to Further Research Collaboration and Open Science 3Health News:The Newly Renamed Resource Center of Somerset Names John Graf, Jr. Director of Development 2Health News:The Newly Renamed Resource Center of Somerset Names John Graf, Jr. Director of Development 3Health News:The Newly Renamed Resource Center of Somerset Names John Graf, Jr. Director of Development 4Health News:Tired Doctors Need More Rest According to New York Medical Malpractice Attorney, David Perecman 2Health News:Tired Doctors Need More Rest According to New York Medical Malpractice Attorney, David Perecman 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: